🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparison of Opioid Utilization in Older Adults with Rheumatoid Arthritis before and after Initiating Biological or Targeted Synthetic Disease-Modifying Antirheumatic Drugs

Drugs - Real World Outcomes(2025)10.1007/s40801-025-00537-3Source: DataRank Database

Comparison of Opioid Utilization in Older Adults with Rheumatoid Arthritis before and after Initiating Biological or Targeted Synthetic Disease-Modifying Antirheumatic Drugs is a research paper published in Drugs - Real World Outcomes (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.00)OA: goldTopics (8)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Shadi Bazzazzadehgan ORCID,Liang-Yuan Lin ORCID,Omkar Ghodke,Sebastian Bruera ORCID,Kaustuv Bhattacharya ORCID

Live enrichment

PubMed:41442071 PMC:PMC13003035 OpenAlex:https://openalex.org/W7117145883

National Institutes of Health, National Institute on Drug Abuse

Grant: 2R15DA046036-02

FWCI

0.00

Citation Percentile

0.6%

goldLicense: cc-by-nc

journalhttps://link.springer.com/content/pdf/10.1007/s40801-025-00537-3.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s40801-025-00537-3.pdf

publisherhttps://link.springer.com/article/10.1007/s40801-025-00537-3

journalhttps://doi.org/10.1007/s40801-025-00537-3

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41442071

Fields of Study

Rheumatoid Arthritis Research and TherapiesOpioid Use Disorder TreatmentMedication Adherence and Compliance

Keywords

Rheumatoid arthritisOpioidAntirheumatic drugsAntirheumatic AgentsArthritis

Sustainable Development Goals

SDG 0: Good health and well-being